Inhalable songorine-integrated lipid nanomedicine for targeted ARDS therapy via repairing endothelial barrier and inactivating NLRP3 inflammasome

Authors:

Abstract
No abstract available
Funding Information
  • Guangzhou University of Chinese Medicine (GZY2025GB0410)
  • State Administration of Traditional Chinese Medicine of the People's Republic of China (ZYYCXTD-D-202203)
  • National Natural Science Foundation of China (82374392)
  • National Natural Science Foundation of China (52173150)
  • Traditional Chinese Medicine Bureau of Guangdong Province (20251152)

This publication has 60 references indexed in Scilit: